Last €51.30 EUR
Change Today +0.242 / 0.47%
Volume 8.4K
MDT On Other Exchanges
New York
As of 4:33 AM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

medtronic inc (MDT) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/19/14 - €52.11
52 Week Low
09/30/13 - €38.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDTRONIC INC (MDT)

medtronic inc (MDT) Details

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group’s products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group’s products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.

49,247 Employees
Last Reported Date: 06/20/14
Founded in 1949

medtronic inc (MDT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.5M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $774.9K
Executive Vice President and Group President ...
Total Annual Compensation: $724.9K
Executive Vice President and Group President ...
Total Annual Compensation: $675.1K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $781.7K
Compensation as of Fiscal Year 2014.

medtronic inc (MDT) Key Developments

Medtronic, Inc. Elects Elizabeth G. Nabel as Director

Medtronic, Inc. announced that its board of directors elected Elizabeth Nabel, M.D., president of Brigham & Women's Hospital and Brigham & Women's Faulkner Hospital, to the board as an independent director. Dr. Nabel will stand for election by shareholders at the company's 2015 annual meeting of Shareholders. Dr. Nabel was appointed to the nominating and corporate governance committee and the quality and technology committee of the board of directors. Previously, Dr. Nabel served for ten years at the National Institutes of Health where she held a variety of roles, including director of the National Heart, Lung and Blood Institute.

Medtronic, Inc. Launches New Balloon Kyphoplasty Products for Treating Spinal Fractures

Medtronic, Inc. announced the launch of the KYPHON Express(TM) II Balloon Kyphoplasty Platform, which includes the next generation KYPHON (R) Cement Delivery System. This new platform is the latest advancement in the KYPHON(R) Balloon Kyphoplasty (BKP) technology for the treatment of vertebral compression fractures. The KYPHON Express(TM) II Balloon Kyphoplasty Platform features a maximum pressure rating of 700 psi, providing the treating physician a more powerful option for reducing fractures. The new system also gives physicians the option of using the cement resistant technique, which allows one balloon to remain inflated during contralateral cement fill, helping to maintain the goal of fracture reduction.1. In addition, this system includes an expanded tools portfolio that is more versatile, allowing for the treatment of a variety of different levels of the spine1. The next-generation KYPHON(R) Cement Delivery System (CDS) includes new features designed to increase the efficiency and precision of delivering bone cement into a vertebral body2. The re-designed cement cartridges can be filled simultaneously with a provided T-adapter, increasing procedure efficiency. In addition, KYPHON(R) CDS now has longer shelf life for enhanced usability. The CDS continues to allow the physician to deliver highly viscous bone cement to the patient from up to 4 feet away from the radiation source while maintaining tactile feel. It also still includes a Quick Release Button that provides the ability to halt the flow of bone cement on demand, giving the physician precise control over the amount of cement flow2.

Ortho Kinematics, Inc. Enters Agreement with Medtronic for Promotion of VMA

Ortho Kinematics, Inc. (OKI) announced that it has entered into an agreement with Medtronic, giving Medtronic the ability to promote OKI's VMA (Vertebral Motion Analysis) test to spine surgeons.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:GR €51.30 EUR +0.242

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDT.
View Industry Companies

Industry Analysis


Industry Average

Valuation MDT Industry Range
No financial data is available for MDT.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at